NLRP3 and metabolic dysfunction-associated steatohepatitis: These data demonstrate a major contribution of PR2X7, possibly via activation of the NLRP3 inflammasome, in hepatic inflammation and injury driving transition from steatosis to NASH in the context of NAFLD.